Thursday, July 28, 2011

Death, injuries, fraud, but no sanctions

Pharma companies conduct phony clinical trials with alarming regularity, but oversight bodies don't seem to care.  Why not?  Read about it in in the New York Times.

No comments:

Post a Comment